The global ocular bromfenac market is a key segment of the ophthalmic therapeutics industry, primarily driven by its use as a non-steroidal anti-inflammatory drug (NSAID) to treat postoperative inflammation and pain following ocular surgeries, particularly cataract extraction. https://www.databridgemarketresearch.com/